Vous n'êtes pas connecté
WEDNESDAY, Sept. 4, 2024 -- The humanized monoclonal antibody directed against the pituitary adenylate cyclase-activating polypeptide (PACAP) ligand, Lu AG09222, is better than placebo for reducing migraine frequency over four weeks, according to a...
New research highlights the benefits of starting monoclonal antibody therapy for medlinkmultiple sclerosis/medlink in childhood. The study,...
THURSDAY, Sept. 11, 2024 -- Two monoclonal antibody treatments to slow Alzheimer's disease, lecanemab (Leqembi) and donanemab (Kisunla), have been...
WEDNESDAY, Sept. 4, 2024 -- Among White, but not Black individuals, urinary cadmium (Cd) concentrations are associated with cognitive impairment,...
FRIDAY, Sept. 13, 2024 -- Once-weekly efsitora is noninferior to once-daily degludec for reducing glycated hemoglobin levels in adults with type 2...
WEDNESDAY, Sept. 4, 2024 -- Plastic surgery patients who use marijuana also have elevated nicotine levels, according to a study published in the...
A monoclonal antibody appears effective at neutralizing the numerous variants of SARS-CoV-2, as well as related viruses in animals that could pose a...
WEDNESDAY, Sept. 11, 2024 -- A proteomic signature indicating increased respiratory susceptibility identifies the risk for respiratory death, incident...
WEDNESDAY, Sept. 4, 2024 -- Women are less likely to return for subsequent screening after false-positive mammography results, according to a study...